Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease

被引:29
作者
Ballestri, Stefano [1 ]
Mantovani, Alessandro [2 ]
Nascimbeni, Fabio [3 ]
Lugari, Simonetta [4 ]
Lonardo, Amedeo [3 ]
机构
[1] UOC Med, Azienda USL Modena, Osped Pavullo, Pavullo nel Frignano, MO, Italy
[2] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[3] UOC Med Ad Indirizzo Metabol Nutrizionist Modena, AOU Modena, Osped Civile Baggiovara, Modena, Italy
[4] Univ Modena & Reggio Emilia, Modena, Italy
关键词
bone mass density; cancer; cardiovascular system; endocrine system; large bowel; metabolic syndrome; PCOS; sarcopenia; uric acid; OBSTRUCTIVE SLEEP-APNEA; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; GROWTH-HORMONE REPLACEMENT; POLYCYSTIC-OVARY-SYNDROME; INDEPENDENT RISK-FACTOR; KOREA NATIONAL-HEALTH; SKELETAL-MUSCLE MASS; TERM-FOLLOW-UP; CARDIOVASCULAR-DISEASE;
D O I
10.4155/fmc-2019-0003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review article aims to synthesize the evidence regarding nonalcoholic fatty liver disease (NAFLD) as a systemic disorder. We critically discuss the metabolic syndrome and its components; the cardiovascular and the endocrine system; chronic respiratory disorders; the musculoskeletal system; the skin; and extrahepatic tumors. We conclude that, while some of these extra-hepatic conditions clearly predispose to the development of secondary forms of NAFLD (typically hypothyroidism-induced NAFLD), others result from pre-existent NAFLD (e.g., certain extra-hepatic tumors) and others (such as Type 2 Diabetes) have, with NAFLD, mutual and bidirectional associations. Analyzed data imply that NAFLD is not merely a hepatic disease. It is also and possibly more importantly, a systemic disorder requiring a special awareness, a multidisciplinary approach and a multidimensional vision.
引用
收藏
页码:2171 / 2192
页数:22
相关论文
共 50 条
  • [41] Nonalcoholic fatty liver disease and vascular risk
    Bhatia, Lokpal S.
    Curzen, Nicholas P.
    Byrne, Christopher D.
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (04) : 420 - 428
  • [42] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
    Carter, Danielle
    Dieterich, Douglas T.
    Chang, Charissa
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +
  • [43] Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
    Xu, Xin
    Lu, Linlin
    Dong, Quanyong
    Li, Xiaolin
    Zhang, Nannan
    Xin, Yongning
    Xuan, Shiying
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [44] Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
    Zein, Claudia O.
    Unalp, Aynur
    Colvin, Ryan
    Liu, Yao-Chang
    McCullough, Arthur J.
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 753 - 759
  • [45] Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?
    Yusuf Yilmaz
    World Journal of Hepatology, 2012, (12) : 332 - 334
  • [47] Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
    Salamone, Federico
    Bugianesi, Elisabetta
    JOURNAL OF HEPATOLOGY, 2010, 53 (06) : 1146 - 1147
  • [48] Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
    Targher, Giovanni
    Byrne, Christopher D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) : 483 - 495
  • [49] Nonalcoholic fatty liver disease and cardiovascular disease
    Hong Liu
    Hong-yun Lu
    World Journal of Gastroenterology, 2014, (26) : 8407 - 8415
  • [50] Nonalcoholic fatty liver disease and polycystic ovary syndrome
    Vassilatou, Evangeline
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (26) : 8351 - 8363